AU634149B2 - Pain-killer - Google Patents

Pain-killer Download PDF

Info

Publication number
AU634149B2
AU634149B2 AU10428/88A AU1042888A AU634149B2 AU 634149 B2 AU634149 B2 AU 634149B2 AU 10428/88 A AU10428/88 A AU 10428/88A AU 1042888 A AU1042888 A AU 1042888A AU 634149 B2 AU634149 B2 AU 634149B2
Authority
AU
Australia
Prior art keywords
der
die
tryptophan
composition
international
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU10428/88A
Other languages
English (en)
Other versions
AU1042888A (en
Inventor
Joachim Kamprad
Ludger Rolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1042888A publication Critical patent/AU1042888A/en
Application granted granted Critical
Publication of AU634149B2 publication Critical patent/AU634149B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
AU10428/88A 1986-12-13 1987-12-10 Pain-killer Ceased AU634149B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3642668 1986-12-13
DE19863642668 DE3642668A1 (de) 1986-12-13 1986-12-13 Schmerzmittel fuer menschen

Publications (2)

Publication Number Publication Date
AU1042888A AU1042888A (en) 1988-06-30
AU634149B2 true AU634149B2 (en) 1993-02-18

Family

ID=6316147

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10428/88A Ceased AU634149B2 (en) 1986-12-13 1987-12-10 Pain-killer

Country Status (11)

Country Link
US (1) US5216019A (enExample)
EP (1) EP0344158B1 (enExample)
JP (1) JPH0645539B2 (enExample)
KR (1) KR960011235B1 (enExample)
AT (1) ATE74505T1 (enExample)
AU (1) AU634149B2 (enExample)
CA (1) CA1320133C (enExample)
DE (2) DE3642668A1 (enExample)
DK (1) DK169120B1 (enExample)
NO (1) NO882724L (enExample)
WO (1) WO1988004170A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004039196B4 (de) * 2004-08-12 2008-07-31 Dr.Kamprad Kg Neue Formulierung für L-Tryptophan
US9173860B2 (en) 2009-11-04 2015-11-03 Susan Park Perrine S isomers of α-methyl hydrocinnamic acid for the treatment of blood disorders
DE102022103658A1 (de) 2022-02-16 2023-08-17 Joachim Kamprad Arzneimittelzusammensetzung enthaltend L-Tryptophan (L-Try) und L-5-Hydroxytryptophan (5-HTP) sowie einen peripheren Abbauhemmer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
DE2908127A1 (de) * 1978-03-03 1979-09-06 Merck Patent Gmbh Verwendung von inhibitoren des abbaus von enkephalinen und endorphinen bei der bekaempfung von schmerzzustaenden sowie zur herstellung pharmazeutischer zubereitungen und arzneimittel
JPS57160227A (en) * 1981-03-30 1982-10-02 Fujitsu Ltd Frequency synthesizer
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
GB2113546A (en) * 1982-01-22 1983-08-10 Mayron International Inc Treatment of migraine
GB2113545A (en) * 1982-01-22 1983-08-10 Mayron International Inc Treatment of migraine
US4639465A (en) * 1985-08-30 1987-01-27 Commonwealth Medical Corporation Of America Method and composition for relieving pain

Also Published As

Publication number Publication date
WO1988004170A1 (fr) 1988-06-16
JPH02500746A (ja) 1990-03-15
NO882724D0 (no) 1988-06-21
DK452788D0 (da) 1988-08-12
DK169120B1 (da) 1994-08-22
KR890700025A (ko) 1989-03-02
AU1042888A (en) 1988-06-30
KR960011235B1 (ko) 1996-08-21
DE3778165D1 (enExample) 1992-05-14
JPH0645539B2 (ja) 1994-06-15
US5216019A (en) 1993-06-01
DK452788A (da) 1988-08-12
NO882724L (no) 1988-10-10
EP0344158B1 (de) 1992-04-08
CA1320133C (en) 1993-07-13
EP0344158A1 (de) 1989-12-06
ATE74505T1 (de) 1992-04-15
DE3642668A1 (de) 1988-06-23

Similar Documents

Publication Publication Date Title
RU2140266C1 (ru) Фармацевтическая композиция с регулируемым выделением на основе одной или нескольких фармацевтически приемлемых солей гамма-гидроксимасляной кислоты и способ ее получения
Browning Neuropsychiatric Illnesses
BR112020003119A2 (pt) método de tratamento de esclerose lateral amiotrófica com pridopidina
JPH06507621A (ja) ベンゾジアゼピンによる治療における改善
Ishikawa et al. Hippocampal degeneration inducing impairment of learning in rats: model of dementia?
CN109498643A (zh) 一种叶酸组合物及其在制备改善老年失智药物中的应用
Tortella et al. Suppressant effects of selective 5-HT2 antagonists on rapid eye movement sleep in rats
EP3641889B1 (en) A composition for treatment or prevention of a neurodegenerative disease
PICHEL WARNER Hyperserotoninemia in functional gastrointestinal disease
US5216019A (en) Pain killer
DE69511453T2 (de) Verwendung einer Kombination von Antineoplastonen zur Herstellung eines Arzneimittels zur Behandlung der Neurofibromatose
JP5634062B2 (ja) 脳機能改善用組成物および脳機能を改善する方法
US12048712B2 (en) Beta-adrenergic agonist and muscarinic antagonist compositions and methods of using
AU2012391533B2 (en) Combination for the prophylaxis and treatment of behavioural, mental and cognitive disorders
AU612140B2 (en) Prevention or interruption of panic states with an imidazobenzodiazepine
Foltin Effects of pharmacological manipulations on “demand” for food by baboons
Jann et al. Alternative drug therapies for mania: a literature review
JPWO2012035871A1 (ja) 脳機能改善用組成物および脳機能を改善する方法
US20070053930A1 (en) Combination therapy for treatment of high cholesterol
JPH0436136B2 (enExample)
Hama Alleviation of neuropathic pain symptoms by adrenal medullary transplants in the rat spinal subarachnoid space
Hearn Effects of 5-HT2 receptor ligands on tail pinch-induced stress responding and open field behavior
Melnick Behavioral sensitization to repeated phencyclidine: mechanisms of action
BR122025001464A2 (pt) Uso de pridopidina e, opcionalmente, de um segundo composto para o tratamento de esclerose lateral amiotrófica (ela) e composição farmacêutica
JPH0465049B2 (enExample)